David McIntosh/LinkedIn
Apr 30, 2026, 16:19
David McIntosh: Plasma Medicines for All with United Plasma Action
David McIntosh, Founder and Chair of United Plasma Action, shared Immune Deficiency Foundation’s, post on LinkedIn:
“Recent enquiries about the United Plasma Action organisation prompt me to share this document more widely with fellow LinkedIners.
We are a small group with a very tightly focussed brief and mission, but it occurs to me that our activities may nevertheless be of interest to a wider audience.”
Find more posts featuring David McIntosh on Hemostasis Today.
-
Apr 30, 2026, 16:19Ifeanyichukwu Ifechidere: Coagulation Fundamentals for Result Interpretation in Clinical Practice
-
Apr 30, 2026, 15:56Benjamin Spurgeon: What’s next for Platelet Function Testing?
-
Apr 30, 2026, 15:38Ahvie Herskowitz: Is It Iron or ‘Oxidized Rust’? – A New Predictor of Aging.
-
Apr 30, 2026, 15:01Neil Morgan: New Collaborative Research Review on Large‐Scale Genetic Analysis in the Bleeding Disorders Community
-
Apr 30, 2026, 14:52Neema Ngugi: Understanding the D-Dimer Test – A Key Tool in Detecting Blood Clots
-
Apr 30, 2026, 14:45Steven Brown: Contributing to AMSSM CRN Orthobiologics Research on PRP in Muscle Injury and Tendinopathy
-
Apr 30, 2026, 14:33Abdul Mannan: The Clinical Pattern That Should Make You Think of VEXAS
-
Apr 30, 2026, 14:28Jennifer Le Mac: How the Immune System Shapes Venous Thrombosis
-
Apr 30, 2026, 14:22Samantha Xavier: Successfully Defended My PhD Thesis on P-Selectin as a Biomarker for Venous Thromboembolism